Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PJ3R
|
|||
| Former ID |
DNC012690
|
|||
| Drug Name |
(Z)-2-Methyl-1-oxazol-2-yl-octadec-9-en-1-one
|
|||
| Synonyms |
CHEMBL37044; (Z)-2-Methyl-1-oxazol-2-yl-octadec-9-en-1-one; BDBM50100866
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H37NO2
|
|||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCC(C)C(=O)C1=NC=CO1
|
|||
| InChI |
1S/C22H37NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(2)21(24)22-23-18-19-25-22/h10-11,18-20H,3-9,12-17H2,1-2H3/b11-10-
|
|||
| InChIKey |
VNDQKKVLWCFNIJ-KHPPLWFESA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | alpha-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and alpha-substitution. Bioorg Med Chem Lett. 2001 Jun 18;11(12):1517-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.